Lakefront Biotherapeutics (GLPGF) FCF Margin Growth (1y) (2015 - 2026)
Powered by 
Analysis
Lakefront Biotherapeutics (GLPGF) FCF Margin Growth (1y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 210.97 Bn | 196.98 Bn | 7.24 Bn | 1,388.00 |
| 2 | Gilead Sciences | 180.98 Bn | 177.80 Bn | 6.22 Bn | 3,383.00 |
| 3 | Vertex Pharmaceuticals | 132.09 Bn | 124.24 Bn | 2.84 Bn | -89.00 |
| 4 | Regeneron Pharmaceuticals | 82.56 Bn | 74.57 Bn | 3.93 Bn | -1,183.00 |
| 5 | Argenx Se | 61.71 Bn | 56.53 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.60 Bn | 49.46 Bn | 52.00 Mn | 26,102.00 |
| 7 | Alnylam Pharmaceuticals | 34.02 Bn | 30.71 Bn | 992.69 Mn | 769.00 |
| 8 | Biogen | 31.25 Bn | 29.97 Bn | 1.96 Bn | 984.00 |
| 9 | Roivant Sciences | 29.76 Bn | 29.76 Bn | 1.16 Mn | -902,489.00 |
| 10 | Lakefront Biotherapeutics | 1.73 Bn | 1.73 Bn | 3.51 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -123,021.00 |
| Dec 31, 2025 | 13,877.00 |
| Sep 30, 2025 | 140.00 |
| Jun 30, 2025 | 1,957.00 |
| Mar 31, 2025 | 14,542.00 |
| Dec 31, 2024 | -7,265.00 |
| Mar 31, 2024 | -3,543.00 |
| Dec 31, 2023 | -35,134.00 |
| Mar 31, 2023 | -11,596.00 |
| Dec 31, 2022 | -25,825.00 |
| Mar 31, 2022 | 6,025.00 |
| Dec 31, 2021 | 61,093.00 |
| Jun 30, 2021 | 8,438.00 |
| Mar 31, 2021 | -3,526.00 |
| Dec 31, 2020 | -6,153.00 |
| Jun 30, 2020 | -2,092.00 |
| Mar 31, 2020 | 14,688.00 |
| Dec 31, 2019 | 12,624.00 |
| Sep 30, 2019 | 46,534.00 |
| Jun 30, 2019 | -1,428.00 |